20500 ā
Medicinal preparations containing organic active ingredients; Phosphorus compounds; Phosphorus acids or esters thereof having PāC bonds, e.g. foscarnet, trichlorfon Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
INJECTABLE THERMORESPONSIVE HYDROGELS AS A COMBINATORY MODALITY FOR CONTROLLED DRUG DELIVERY, BIOMATERIAL IMPLANT AND 3D PRINTING BIOINK
#2USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
#3COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#4METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#5Formulation of lecithin-modified calcium phosphate nanoparticles with an enhanced cellar uptake as a carrier for bisphosphonates and a method of preparing thereof
#6MEVALONATE PATHWAY INHIBITOR AS HIGHLY-EFFICIENT VACCINE ADJUVANT
#7PREVENTION OF SYMPATHETIC DENERVATION OF THE PINEAL GLAND IN CARDIAC DISEASE
#8Methods Of Treating Decreased Bone Mineral Density With Cluster Of Differentiation 109 (CD109) Inhibitors
#9AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE
#10POTENTIATION OF DURABLE ANTITUMOR IMMUNITY BY MULTIFACTORIAL IMMUNE MODULATION
#11USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
#12SULFONATED AND PHOSPHORYLATED AROMATIC MOLECULES
#13USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES
#14METHODS FOR ENHANCED NUCLEIC ACID DELIVERY
#15SYSTEMS AND METHODS FOR MANAGEMENT AND TREATMENT OF BONE CONDITIONS
#16METHODS OF BOOSTING THYMIC REGENERATION IN PATIENTS SUFFERING FROM A THYMIC INJURY BY USING RANKL
#17COMBINATION THERAPIES FOR THE TREATMENT OF DISEASES
#18COMPOSITIONS AND METHODS OF TREATING SARCOMA LUNG METASTASIS
#19Treatment of Moderate-to-Severe Osteogenesis Imperfecta
#20Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
#21NANOPLATFORM FOR TARGETING MACROPHAGE AND COMPOSITION FOR PREVENTION OR TREATMENT OF METASTATIC CANCER
#22PHOSPHOLIPID COMPOUNDS AND FORMULATIONS
#23COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#24METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#25COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#26Methods of Enhancing Non-Viral Gene Therapy
#27USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
#28Therapeutic treatment of breast cancer based on c-MAF status
#29ADJUVANT CONTAINING ZINC ALUMINUM RISEDRONATE, AND APPLICATION THEREOF
#30THERAPEUTIC TREATMENT OF BREAST CANCER BASED ON C-MAF STATUS
#31Targeting Microbubbles
#32BIOCOMPATIBLE STRUCTURE COMPRISING HOLLOW CAGE, AND MANUFACTURING METHOD THEREFOR
#33INHIBITORS OF ENPP1 AND METHODS OF USING SAME
#34USE OF NERIDRONIC ACID OR OF ITS SALT FOR THE TREATMENT OF OSTEOARTHROSIS
#35TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING IN CANCERS WITH LOW IMMUNOGENICITY
#36COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTION-INDUCED CARDIOMYOPATHY
#37Use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or treating viral pneumonia
#38TREATMENT OF OSTEOGENESIS IMPERFECTA
#39Refillable Implantable Device for Delivering a Drug Compound
#40Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
#41THERAPEUTIC COMPOSITION AND ADMINISTRATION METHODS FOR INCREASING OSSEOINTEGRATION WITH DENTAL IMPLANTS, GRAFT MATERIALS AND PRF
#42Method of treating urolithiasis
#43MEVALONATE PATHWAY INHIBITOR AS HIGHLY-EFFICIENT VACCINE ADJUVANT
#44Methods of manufacturing microspheres
#45INHIBITOR OF BINDING BETWEEN PODOCIN AND KERATIN 8 FOR USE IN THE TREATMENT OF NEPHROTIC SYNDROME
#46BONE-BINDING COMPOUNDS
#47METHODS OF BOOSTING THYMIC REGENERATION IN PATIENTS SUFFERING FROM A THYMIC INJURY BY USING RANKL
#48COMPOSITIONS AND METHODS FOR BONE REPAIR AND BONE HEALTH
#49USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
#50Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell
#51DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES
#52METHODS FOR TREATING COLORECTAL CANCER
#53COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#54COMPOSITION FOR IMPROVED BONE FRACTURE HEALING
#55COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#56Targeting microbubbles
#57SELF-EMULSIFYING FORMULATION OF BISPHOSPHONATES AND ASSOCIATED DOSAGE FORMS
#58Compositions and Methods for use of CXCL12 in Treatment of Bone Disorders
#59TREATING INFLAMMATION USING LLP2A-BISPHOSPHONATE CONJUGATES AND MESENCHYMAL STEM CELLS
#60Peptides for activation of cell signaling in osteoprogenitor cells
#61Compositions and methods of treating sarcoma lung metastasis
#62CAR T-cells for the treatment of bone metastatic cancer
#63METHODS AND COMPOSITIONS FOR THE EXPANSION AND USE OF ALLOGENEIC GAMMA/DELTA-T CELLS
#64Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell
#65TREATMENT AND PREVENTION OF BONE LOSS USING RESOLVINS
#66A BIOMARKER AND TARGET FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF ANKYLOSING SPONDYLITIS
#67LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#68Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#69Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
#70TRANSMUCOSAL DRUG DELIVERY SYSTEM
#71Phospholipid compounds and formulations
#72Synthesis and application of microbubble-forming compounds
#73INJECTABLE THERMORESPONSIVE HYDROGELS AS A COMBINATORY MODALITY FOR CONTROLLED DRUG DELIVERY, BIOMATERIAL IMPLANT AND 3D PRINTING BIOINK
#74Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
#75METHODS OF TREATING OSTEONECROSIS WITH LLP2A-BISPHOSPHONATE COMPOUNDS
#76Compounds and methods for the targeted degradation of androgen receptor
#77Therapeutic treatment of breast cancer based on c-MAF status
#78Skeletal removal of bisphosphonates
#79INHIBITORS OF ENPP1 AND METHODS OF USING SAME
#80ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF
#81Method for bone tissue regeneration in experiments
#82Treatment of lysosomal storage disorders
#83COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR
#84Self-emulsifying formulation of bisphosphonates and associated dosage forms
#85Phosphate derivatives and use thereof
#86NANOCOCHLEATE FORMULATION AND METHOD OF PREPARING THE NANOCOCHLEATE FORMULATION
#87USE OF A BISPHOSPHONATE SALT IN A MEDICAMENT FOR A NATURALLY OCCURRING DISEASE/DISORDER IN A MAMMAL
#88LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#89Compounds for treating CMV related diseases
#90Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis
#91METHOD FOR BONE TISSUE REGENERATION IN EXPERIMENTS
#92APPLICATIONS OF SPERMINE AND DERIVATIVES THEREOF
#93Targeting Macrophages to Modulate Electrical Conduction in the Heart
#94Transdermal therapeutic system on the basis of adhesive plasticizer-polymer matrices
#95ADJUNCTIVE THERAPY WITH 25-HYDROXYVITAMIN D
#96Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
#97Synthesis and application of microbubble-forming compounds
#98SEVELAMER FOR THE TREATMENT AND/OR PREVENTION OF AORTIC STENOSIS
#99Ibandronate conjugates of nucleoside antimetabolites
#100PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OSTEOARTHRITIS CONTAINING CLODRONIC ACID AND HYALURONIC ACID
#101AQUEOUS DRUG DELIVERY SYSTEM
#102Compositions of medium chaintryglycerides (MCT) and plant-based nutrients for brain health
#103Composition for treating chronic renal transplant dysfunction comprising bisphosphonate
#104Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#105Compositions and products for use in the treatment of bone fractures and defects
#106Method for the treatment of osteoarthritis
#107Methods of boosting thymic regeneration in patients suffering from a thymic injury by using RANKL
#108DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES
#109Prodrug compounds and their uses
#110PHARMACEUTICAL COMPOSITION CONTAINING INSULIN-LIKE GROWTH FACTOR-2 AND USE THEREOF
#111COMBINATIONS OF GENISTEIN AND BISPHOSPHONATES
#112Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
#113METHODS OF TREATING COMPLEX REGIONAL PAIN SYNDROME (CRPS) OR SYMPTOMS COMPRISING ADMINISTRATION OF NERIDRONIC ACID
#114IMPROVED METHODS FOR INHIBITING STENOSIS, OBSTRUCTION, OR CALCIFICATION OF A STENTED HEART VALVE OR BIOPROSTHESIS
#115Mevalonate pathway inhibitor as highly-efficient vaccine adjuvant
#116Compositions for oral administration of zoledronic acid or related compounds for treating disease
#117Polymorph of sodium neridronate and preparation process thereof
#118Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
#119Targeting microbubbles
#120Therapeutic treatment of breast cancer based on c-MAF status
#121Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof
#122Pharmaceutical preparation treating bone lesions caused by malignant neoplasms
#123Metal complexes with bisphophonate or pyrophosphate useful as imaging agents
#124Trk-inhibiting compound
#125Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
#126METHOD FOR PRODUCING NK CELL-ENRICHED BLOOD PREPARATION
#127Pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (AML)
#128Skeletal removal of bisphosphonates
#129Applications of spermine and derivatives thereof
#130INHIBITORS OF ENPP1 AND METHODS OF USING SAME
#131Methods for expanding and activating Ī³Ī“ T cells for the treatment of cancer and related malignancies
#132USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
#133NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#134USE OF A BISPHOSPHONATE SALT IN A MEDICAMENT FOR A NATURALLY OCCURRING DISEASE/DISORDER IN A MAMMAL
#135Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#136METHODS AND COMPOSITIONS FOR DETECTING ANEURYSMS
#137Method of Treating Acute Coronary Syndromes
#138COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#139Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents
#140NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#141METHODS OF TREATING OSTEONECROSIS WITH LLP2A-BISPHOSPHONATE COMPOUNDS
#142PHARMACEUTICAL COMPOSITION OF ENTECAVIR AND PROCESS OF MANUFACTURING
#143Targeting Macrophages to Modulate Electrical Conduction in the Heart
#144NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#145Method using enteric-coated etidronate for treating calcification, hypercalcaemia, and calcinosis of the brain and other organs
#146TREATMENT AND PREVENTION OF BONE LOSS USING RESOLVINS
#147Targeting microbubbles
#148Stable dosage form of etidronate-cytarabine conjugate, and use thereof
#149Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
#150NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#151Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#152NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#153Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders
#154DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#155Bisphosphonic acid compound
#156COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#157Compositions and methods of treating sarcoma lung metastasis
#158Neridronic acid for treating complex regional pain syndrome
#159BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#160Prodrug compounds and uses thereof
#161Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#162Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#163Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#164Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell
#165COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
#166AQUEOUS DRUG DELIVERY SYSTEM
#167Trk-inhibiting compound
#168Neridronic acid for treating complex regional pain syndrome
#169Compositions for oral administration of zoledronic acid or related compounds for treating disease
#170Compositions for oral administration of zoledronic acid or related compounds for treating disease
#171Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#172ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF
#173Method to achieve extended expression of DNA infused into liver
#174PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OSTEOARTHRITIS CONTAINING CLODRONIC ACID AND HYALURONIC ACID
#175Synthesis and application of microbubble-forming compounds
#176M-CSF Specific Monoclonal Antibody and Uses Thereof
#177Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
#178Osteoclast inhibitors such as zoledronic acid for low back pain treatment
#179Antibacterial bismuth complexes
#180Bisphosphonates vinylic monomers and polymers and uses thereof
#181COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING ARTHRITIS
#182COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#183BISPHOSPHONATE COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE
#184Self-emulsifying formulation of bisphosphonates and associated dosage forms
#185Neridronic acid for treating arthritis
#186Neridronic acid for treating complex regional pain syndrome
#187Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#188Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#189Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#190Neridronic acid for treating complex regional pain syndrome
#191USE OF BISPHOSPHONATES AS HIV/AIDS ADJUNCTIVE TREATMENT
#192Compositions for administration of zoledronic acid or related compounds for treating low back pain
#193Method of treating acute coronary syndromes
#194COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#195Neridronic acid for treating complex regional pain syndrome
#196Antibody targeting osteoclast-related protein Siglec-15
#197Neridronic acid for treating complex regional pain syndrome
#198Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#199Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor
#200Osteoclast inhibitors for joint conditions
#201Neridronic acid for treating complex regional pain syndrome
#202Crystallization method and bioavailability
#203Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
#204USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
#205Trk-inhibiting compound
#206Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
#207SUSTAINED AND REVERSIBLE ORAL DRUG DELIVERY SYSTEMS
#208Hydrosoluble hydroxybisphosphonic derivatives of doxorubicin
#209Molecules for bone tissue regeneration
#210AAV-Based Gene Therapy
#211Neridronic acid for treating complex regional pain syndrome
#212Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity
#213Compositions for administration of zoledronic acid or related compounds for treating low back pain
#214Neridronic acid molecular complex for treating complex regional pain syndrome
#215Treatment and prevention of cardiovascular disease and thrombosis
#216USE OF NERIDRONIC ACID OR OF ITS SALT FOR THE TREATMENT OF OSTEOARTHROSIS
#217Osteoclast inhibitors for knee conditions
#218LLP2A-bisphosphonate conjugates for osteoporosis treatment
#219Neridronic acid for treating bone marrow lesions
#220Prodrug compounds and uses therof
#221Osteoclast inhibitors for joint conditions
#222M-CSF specific monoclonal antibody and uses thereof
#223COMPOSITIONS AND PRODUCTS FOR USE IN THE TREATMENT OF BONE FRACTURES AND DEFECTS
#224COMPOSITION OF DIALYSIS LIQUID COMPRISING CRYSTALLISATION INHIBITOR SUBSTANCES
#225Inorganic-organic hybrid compound
#226CELL DELIVERY SYSTEM AND METHOD
#227Method of treating acute coronary syndromes
#228Neridronic acid molecular complex for treating complex regional pain syndrome
#229Osteoclast inhibitors for knee conditions
#230Neridronic acid for treating bone marrow lesion
#231Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#232Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#233Neridronic acid for treating complex regional pain syndrome
#234Neridronic acid for treating pain associated with a joint
#235Prodrug compounds and their uses
#236Osteoclast inhibitors for knee conditions
#237Trk-inhibiting compound
#238Use of derivatives containing C-O-P bonds in patients with kidney failure
#239COMBINATION THERAPEUTIC NANOPARTICLES
#240INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS
#241Targeting microbubbles
#242Precise delivery of therapeutic agents to cell mitochondria for anti-cancer therapy
#243Osteoclast inhibitors for bone marrow lesions
#244Osteoclast inhibitors for joint conditions
#245Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis
#246METHODS AND KITS FOR IDENTIFYING SUSCEPTIBILITY TO ANTIRESORPTIVE-AGENT-INDUCED OSTEONECROSIS OF THE JAW
#247Trk-inhibiting compound
#248Cell-free tissued engineered vascular grafts
#249TREATING INFLAMMATION USING LLP2A-BISPHOSPHONATE CONJUGATES AND MESENCHYMAL STEM CELLS
#250Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#251Osteoclast inhibitors for knee conditions
#252Osteoclast inhibitors for knee conditions
#253Synergistic antimicrobial composition
#254Osteoclast inhibitors such as zoledronic acid for low back pain treatment
#255Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#256Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone
#257Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#258Transmucosal hormone delivery system
#259Osteoclast inhibitors for knee conditions
#260Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
#261SOLID COMPOSITION FOR ORAL ADMINISTRATION CONTAINING IBANDRONIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND VITAMIN D
#262Enteric Soft Capsules
#263Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
#264Bone targeted therapeutics and methods of making and using the same
#265Osteoclast inhibitors for knee conditions
#266Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
#267LLP2A-bisphosphonate conjugates for osteoporosis treatment
#268TREATMENT OF PROXIMAL SPINAL MUSCULAR ATROPHY
#269Biophosphonate compounds and gamma delta T cell-mediated therapy for treating epstein-barr virus-associated disorders
#270COMBINATION THERAPEUTIC NANOPARTICLES
#271Osteoclast inhibitors such as zoledronic acid for low back pain treatment
#272Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#273Solid dosage form of coated bisphosphonate particles
#274M-CSF specific monoclonal antibody and uses therof
#275Trk-inhibiting compound
#276COMPOSITION OF DIALYSIS LIQUID COMPRISING CRYSTALLISATION INHIBITOR SUBSTANCES
#277Compositions and Methods for the Prevention and Treatment of Osteolysis and Osteoporosis
#278Antibody targeting osteoclast-related protein siglec-15
#279Use of bisphosphonates as HIV/AIDS adjunctive treatment
#280Therapeutic bisphosphonates
#281Composition and method for treating a hematological malignancy
#282Small molecule drug release from in situ forming degradable scaffolds incorporating hydrogels and bioceramic microparticles
#283METHOD FOR INDUCING IL-2-FREE PROLIFERATION OF GAMMA DELTA T CELLS
#284Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods and making and using thereof
#285Transdermal venous access locking solutions
#286DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES
#287Aqueous drug delivery system
#288Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation
#289TRANSMUCOSAL DRUG DELIVERY SYSTEM
#290Bisphosphonates vinylic monomers and polymers and uses thereof
#291LONG TERM SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING AQUEOUS SUSPENSION OF BISPHOSPHONATE
#292LONG TERM SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING AQUEOUS SUSPENSION OF BISPHOSPHONATE
#293Osteoclast inhibitors for knee conditions
#294Osteoclast inhibitors for knee conditions
#295Osteoclast inhibitors for knee conditions
#296METHOD FOR BONE TISSUE REGENERATION IN EXPERIMENTS
#297Compositions and methods for treating or preventing osteoarthritis
#298Osteoclast inhibitors for knee conditions
#299COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
#3006-oxopurine phosphoribosyltransferase inhibitors